Concepts (409)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Resistance Training | 65 | 2022 | 190 | 19.830 |
Why?
|
| Muscle, Skeletal | 90 | 2022 | 578 | 16.680 |
Why?
|
| Muscle Strength | 52 | 2021 | 214 | 11.480 |
Why?
|
| Regional Blood Flow | 47 | 2020 | 159 | 10.350 |
Why?
|
| Exercise | 44 | 2022 | 442 | 7.620 |
Why?
|
| Muscle Contraction | 26 | 2021 | 161 | 5.550 |
Why?
|
| Body Composition | 38 | 2022 | 260 | 4.930 |
Why?
|
| Bone Density | 24 | 2022 | 99 | 4.140 |
Why?
|
| Vibration | 16 | 2022 | 78 | 3.960 |
Why?
|
| Male | 135 | 2022 | 12842 | 3.510 |
Why?
|
| Young Adult | 66 | 2022 | 2576 | 3.500 |
Why?
|
| Blood Pressure | 15 | 2017 | 351 | 3.300 |
Why?
|
| Adaptation, Physiological | 21 | 2019 | 158 | 3.230 |
Why?
|
| Adult | 109 | 2022 | 7359 | 3.150 |
Why?
|
| Humans | 178 | 2022 | 26777 | 3.100 |
Why?
|
| Isometric Contraction | 19 | 2022 | 117 | 3.050 |
Why?
|
| Tourniquets | 9 | 2017 | 15 | 3.030 |
Why?
|
| Leg | 14 | 2019 | 131 | 2.850 |
Why?
|
| Exercise Test | 12 | 2020 | 246 | 2.840 |
Why?
|
| Aging | 19 | 2021 | 943 | 2.730 |
Why?
|
| Ischemia | 6 | 2017 | 83 | 2.600 |
Why?
|
| Absorptiometry, Photon | 26 | 2022 | 100 | 2.500 |
Why?
|
| Muscle Fatigue | 12 | 2022 | 74 | 2.470 |
Why?
|
| Lower Extremity | 11 | 2017 | 82 | 2.430 |
Why?
|
| Female | 93 | 2022 | 14421 | 2.280 |
Why?
|
| Quadriceps Muscle | 7 | 2020 | 59 | 2.170 |
Why?
|
| Basketball | 3 | 2021 | 4 | 2.160 |
Why?
|
| Thigh | 12 | 2017 | 39 | 2.150 |
Why?
|
| Physical Exertion | 8 | 2020 | 98 | 2.130 |
Why?
|
| Brachial Artery | 5 | 2017 | 36 | 2.040 |
Why?
|
| Athletic Performance | 8 | 2020 | 44 | 2.000 |
Why?
|
| Perception | 5 | 2016 | 82 | 1.910 |
Why?
|
| Middle Aged | 62 | 2021 | 6796 | 1.890 |
Why?
|
| Physical Endurance | 13 | 2016 | 86 | 1.780 |
Why?
|
| Adolescent | 41 | 2020 | 2952 | 1.720 |
Why?
|
| Athletes | 7 | 2021 | 68 | 1.690 |
Why?
|
| Arm | 9 | 2021 | 35 | 1.640 |
Why?
|
| Vascular Stiffness | 4 | 2017 | 41 | 1.620 |
Why?
|
| Weight Lifting | 13 | 2020 | 46 | 1.610 |
Why?
|
| Analysis of Variance | 24 | 2015 | 388 | 1.530 |
Why?
|
| Aged | 42 | 2021 | 5157 | 1.520 |
Why?
|
| Sarcopenia | 5 | 2019 | 41 | 1.510 |
Why?
|
| Time Factors | 23 | 2019 | 1564 | 1.510 |
Why?
|
| Hemodynamics | 9 | 2021 | 220 | 1.500 |
Why?
|
| Range of Motion, Articular | 7 | 2015 | 57 | 1.390 |
Why?
|
| Bicycling | 6 | 2016 | 36 | 1.350 |
Why?
|
| Multiple Sclerosis | 5 | 2020 | 80 | 1.350 |
Why?
|
| Bone and Bones | 8 | 2021 | 74 | 1.320 |
Why?
|
| Hypertrophy | 10 | 2021 | 37 | 1.290 |
Why?
|
| Osteoporosis | 7 | 2018 | 63 | 1.280 |
Why?
|
| Torque | 11 | 2015 | 90 | 1.280 |
Why?
|
| Cross-Over Studies | 13 | 2021 | 124 | 1.240 |
Why?
|
| Hand Strength | 4 | 2021 | 33 | 1.150 |
Why?
|
| Physical Education and Training | 7 | 2011 | 45 | 1.140 |
Why?
|
| Creatine | 5 | 2010 | 32 | 1.110 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2018 | 464 | 1.030 |
Why?
|
| Cross-Sectional Studies | 21 | 2022 | 909 | 1.020 |
Why?
|
| Vascular Resistance | 4 | 2012 | 50 | 1.000 |
Why?
|
| Geriatric Assessment | 4 | 2019 | 86 | 1.000 |
Why?
|
| Arteries | 7 | 2013 | 64 | 0.990 |
Why?
|
| Premenopause | 4 | 2021 | 20 | 0.990 |
Why?
|
| Dietary Supplements | 8 | 2019 | 213 | 0.980 |
Why?
|
| Tibia | 8 | 2021 | 38 | 0.950 |
Why?
|
| Postural Balance | 4 | 2020 | 38 | 0.940 |
Why?
|
| Electromyography | 15 | 2021 | 171 | 0.940 |
Why?
|
| Testosterone | 4 | 2013 | 70 | 0.940 |
Why?
|
| Weight-Bearing | 6 | 2017 | 37 | 0.930 |
Why?
|
| Postmenopause | 9 | 2022 | 83 | 0.930 |
Why?
|
| Lactic Acid | 6 | 2018 | 89 | 0.910 |
Why?
|
| Body Weight | 5 | 2019 | 246 | 0.890 |
Why?
|
| Hypertension | 3 | 2017 | 304 | 0.880 |
Why?
|
| Adipose Tissue | 9 | 2022 | 179 | 0.860 |
Why?
|
| Blood Pressure Determination | 4 | 2015 | 26 | 0.860 |
Why?
|
| Blood Circulation | 2 | 2014 | 12 | 0.850 |
Why?
|
| Physical Conditioning, Human | 2 | 2020 | 13 | 0.850 |
Why?
|
| Reproducibility of Results | 12 | 2020 | 748 | 0.820 |
Why?
|
| Ultrasonography | 12 | 2016 | 228 | 0.820 |
Why?
|
| Interleukin-6 | 2 | 2022 | 190 | 0.810 |
Why?
|
| Recovery of Function | 4 | 2015 | 111 | 0.790 |
Why?
|
| Arterial Pressure | 4 | 2017 | 9 | 0.760 |
Why?
|
| Oxygen | 2 | 2013 | 217 | 0.750 |
Why?
|
| Myalgia | 4 | 2016 | 20 | 0.750 |
Why?
|
| Motor Skills | 3 | 2020 | 32 | 0.740 |
Why?
|
| Stroke | 2 | 2015 | 233 | 0.720 |
Why?
|
| Age Factors | 12 | 2017 | 714 | 0.710 |
Why?
|
| Warm-Up Exercise | 1 | 2020 | 2 | 0.710 |
Why?
|
| Baseball | 1 | 2020 | 10 | 0.700 |
Why?
|
| Plasma Volume | 2 | 2017 | 6 | 0.700 |
Why?
|
| Upper Extremity | 4 | 2017 | 26 | 0.700 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 915 | 0.700 |
Why?
|
| Models, Cardiovascular | 2 | 2017 | 46 | 0.680 |
Why?
|
| Interoception | 1 | 2019 | 20 | 0.670 |
Why?
|
| Adiposity | 6 | 2021 | 87 | 0.670 |
Why?
|
| Blood Flow Velocity | 6 | 2017 | 63 | 0.670 |
Why?
|
| Amputation | 3 | 2017 | 42 | 0.660 |
Why?
|
| Biomarkers | 9 | 2022 | 731 | 0.650 |
Why?
|
| Veins | 3 | 2013 | 19 | 0.650 |
Why?
|
| Vitamin D | 1 | 2019 | 44 | 0.640 |
Why?
|
| Anthropometry | 8 | 2015 | 93 | 0.620 |
Why?
|
| Nutritional Status | 1 | 2019 | 73 | 0.620 |
Why?
|
| Muscles | 6 | 2018 | 70 | 0.610 |
Why?
|
| Extremities | 2 | 2014 | 22 | 0.580 |
Why?
|
| Muscle Development | 1 | 2017 | 7 | 0.570 |
Why?
|
| Organ Size | 7 | 2017 | 83 | 0.550 |
Why?
|
| Bone Resorption | 2 | 2015 | 23 | 0.520 |
Why?
|
| Biomechanical Phenomena | 7 | 2015 | 160 | 0.510 |
Why?
|
| Sex Factors | 7 | 2020 | 444 | 0.500 |
Why?
|
| Cryotherapy | 1 | 2014 | 10 | 0.490 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 259 | 0.490 |
Why?
|
| Gait | 1 | 2015 | 58 | 0.480 |
Why?
|
| Osteogenesis | 1 | 2015 | 40 | 0.480 |
Why?
|
| Equipment Design | 5 | 2015 | 211 | 0.470 |
Why?
|
| Models, Biological | 3 | 2012 | 446 | 0.470 |
Why?
|
| Hormesis | 1 | 2014 | 3 | 0.460 |
Why?
|
| Shoulder Joint | 1 | 2013 | 9 | 0.460 |
Why?
|
| Pulse Wave Analysis | 4 | 2015 | 29 | 0.450 |
Why?
|
| Lactates | 1 | 2013 | 18 | 0.450 |
Why?
|
| Movement | 2 | 2010 | 91 | 0.430 |
Why?
|
| Foot Orthoses | 1 | 2012 | 3 | 0.420 |
Why?
|
| Edema | 1 | 2012 | 18 | 0.420 |
Why?
|
| Bed Rest | 1 | 2012 | 6 | 0.420 |
Why?
|
| Heart Rate | 7 | 2021 | 374 | 0.410 |
Why?
|
| Pressure | 4 | 2014 | 88 | 0.410 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2012 | 23 | 0.410 |
Why?
|
| Follow-Up Studies | 8 | 2017 | 980 | 0.400 |
Why?
|
| Dietary Proteins | 3 | 2010 | 30 | 0.400 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 152 | 0.400 |
Why?
|
| Muscle Cells | 1 | 2011 | 15 | 0.390 |
Why?
|
| Muscle Stretching Exercises | 3 | 2021 | 19 | 0.390 |
Why?
|
| Body Fluid Compartments | 1 | 2011 | 4 | 0.390 |
Why?
|
| Neuromuscular Junction | 3 | 2009 | 21 | 0.380 |
Why?
|
| Hypotension | 1 | 2011 | 18 | 0.380 |
Why?
|
| Safety | 1 | 2011 | 32 | 0.380 |
Why?
|
| Chronic Pain | 2 | 2022 | 58 | 0.380 |
Why?
|
| Physical Fitness | 6 | 2012 | 61 | 0.370 |
Why?
|
| Fatigue | 4 | 2022 | 57 | 0.370 |
Why?
|
| Circulating MicroRNA | 2 | 2022 | 10 | 0.370 |
Why?
|
| Functional Laterality | 2 | 2021 | 61 | 0.360 |
Why?
|
| Models, Theoretical | 1 | 2011 | 129 | 0.360 |
Why?
|
| Reference Values | 5 | 2012 | 197 | 0.350 |
Why?
|
| Electric Stimulation | 1 | 2011 | 253 | 0.350 |
Why?
|
| Physical Examination | 1 | 2010 | 47 | 0.350 |
Why?
|
| Research Design | 3 | 2020 | 174 | 0.350 |
Why?
|
| Lumbar Vertebrae | 7 | 2020 | 122 | 0.340 |
Why?
|
| Pectoralis Muscles | 4 | 2019 | 12 | 0.340 |
Why?
|
| Constriction | 4 | 2015 | 14 | 0.340 |
Why?
|
| Vasoconstriction | 1 | 2009 | 41 | 0.330 |
Why?
|
| Oklahoma | 6 | 2013 | 970 | 0.330 |
Why?
|
| Synaptic Transmission | 1 | 2009 | 48 | 0.330 |
Why?
|
| Blood Vessels | 1 | 2009 | 58 | 0.320 |
Why?
|
| Whey | 1 | 2008 | 3 | 0.310 |
Why?
|
| Running | 5 | 2015 | 39 | 0.310 |
Why?
|
| Random Allocation | 4 | 2018 | 148 | 0.300 |
Why?
|
| Long-Term Potentiation | 1 | 2007 | 4 | 0.290 |
Why?
|
| Exercise Tolerance | 3 | 2016 | 82 | 0.290 |
Why?
|
| Sex Characteristics | 4 | 2020 | 162 | 0.290 |
Why?
|
| Energy Intake | 2 | 2017 | 67 | 0.280 |
Why?
|
| Exercise Therapy | 2 | 2017 | 77 | 0.280 |
Why?
|
| Football | 4 | 2004 | 68 | 0.280 |
Why?
|
| Hand | 2 | 2021 | 25 | 0.280 |
Why?
|
| Physical Therapy Modalities | 2 | 2020 | 44 | 0.270 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 473 | 0.270 |
Why?
|
| Dancing | 1 | 2006 | 13 | 0.270 |
Why?
|
| Body Mass Index | 10 | 2021 | 384 | 0.270 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 11 | 0.260 |
Why?
|
| Signal Transduction | 1 | 2012 | 1337 | 0.260 |
Why?
|
| Energy Metabolism | 2 | 2006 | 177 | 0.250 |
Why?
|
| Pain Threshold | 3 | 2022 | 89 | 0.250 |
Why?
|
| Double-Blind Method | 6 | 2016 | 398 | 0.250 |
Why?
|
| Collagen Type I | 3 | 2015 | 27 | 0.240 |
Why?
|
| Alkaline Phosphatase | 3 | 2015 | 31 | 0.240 |
Why?
|
| Knee | 2 | 2021 | 25 | 0.240 |
Why?
|
| Health Status | 2 | 2017 | 145 | 0.240 |
Why?
|
| Obesity | 3 | 2021 | 648 | 0.240 |
Why?
|
| Motor Activity | 3 | 2021 | 144 | 0.230 |
Why?
|
| Nylons | 2 | 2014 | 2 | 0.230 |
Why?
|
| Skinfold Thickness | 4 | 2011 | 19 | 0.230 |
Why?
|
| Pain | 2 | 2019 | 252 | 0.220 |
Why?
|
| Elasticity | 2 | 2014 | 49 | 0.220 |
Why?
|
| Risk Factors | 4 | 2019 | 2009 | 0.220 |
Why?
|
| Hip Joint | 3 | 2012 | 18 | 0.220 |
Why?
|
| Track and Field | 2 | 2018 | 4 | 0.220 |
Why?
|
| Compliance | 3 | 2011 | 21 | 0.210 |
Why?
|
| Hematocrit | 3 | 2018 | 26 | 0.210 |
Why?
|
| Ultrasonography, Doppler | 2 | 2013 | 22 | 0.210 |
Why?
|
| Elbow | 3 | 2019 | 15 | 0.210 |
Why?
|
| Femur Neck | 2 | 2021 | 5 | 0.210 |
Why?
|
| Peptides | 3 | 2015 | 279 | 0.200 |
Why?
|
| Pain Perception | 1 | 2022 | 17 | 0.200 |
Why?
|
| Ankle Brachial Index | 2 | 2012 | 34 | 0.200 |
Why?
|
| Oxygen Consumption | 5 | 2021 | 173 | 0.200 |
Why?
|
| Mouthwashes | 1 | 2022 | 4 | 0.200 |
Why?
|
| Hamstring Muscles | 1 | 2021 | 3 | 0.200 |
Why?
|
| Soccer | 2 | 2020 | 49 | 0.200 |
Why?
|
| Phosphocreatine | 1 | 2001 | 22 | 0.200 |
Why?
|
| Chronic Disease | 2 | 2022 | 263 | 0.200 |
Why?
|
| Joints | 2 | 2015 | 12 | 0.190 |
Why?
|
| High-Intensity Interval Training | 1 | 2021 | 9 | 0.190 |
Why?
|
| Elbow Joint | 1 | 2001 | 22 | 0.190 |
Why?
|
| Feedback, Sensory | 1 | 2021 | 3 | 0.190 |
Why?
|
| Illusions | 1 | 2021 | 4 | 0.190 |
Why?
|
| Urinalysis | 1 | 2021 | 10 | 0.190 |
Why?
|
| Femur | 3 | 2010 | 21 | 0.190 |
Why?
|
| Retrospective Studies | 2 | 2021 | 2426 | 0.190 |
Why?
|
| Visual Perception | 1 | 2021 | 44 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2022 | 1216 | 0.180 |
Why?
|
| H-Reflex | 1 | 2020 | 4 | 0.180 |
Why?
|
| Universities | 1 | 2021 | 115 | 0.180 |
Why?
|
| Sports Equipment | 1 | 2020 | 4 | 0.180 |
Why?
|
| Students | 2 | 2018 | 188 | 0.170 |
Why?
|
| Time and Motion Studies | 1 | 2019 | 7 | 0.170 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 38 | 0.170 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.170 |
Why?
|
| Refractory Period, Electrophysiological | 2 | 2009 | 21 | 0.170 |
Why?
|
| Periodicity | 2 | 2009 | 17 | 0.170 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2017 | 9 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 47 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 51 | 0.170 |
Why?
|
| Diet Records | 1 | 2019 | 10 | 0.160 |
Why?
|
| Pain Measurement | 1 | 2019 | 159 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2022 | 280 | 0.160 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 27 | 0.160 |
Why?
|
| Activities of Daily Living | 2 | 2015 | 100 | 0.160 |
Why?
|
| Triglycerides | 1 | 2019 | 117 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 43 | 0.160 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 23 | 0.160 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 31 | 0.150 |
Why?
|
| Blood Glucose | 2 | 2019 | 300 | 0.150 |
Why?
|
| Shoulder | 1 | 1997 | 7 | 0.150 |
Why?
|
| Cholesterol | 1 | 2019 | 182 | 0.150 |
Why?
|
| Task Performance and Analysis | 2 | 2010 | 37 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2017 | 5 | 0.150 |
Why?
|
| Artificial Limbs | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nonlinear Dynamics | 1 | 2017 | 17 | 0.140 |
Why?
|
| Porosity | 1 | 2017 | 38 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2017 | 66 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2019 | 701 | 0.140 |
Why?
|
| Forearm | 2 | 2014 | 36 | 0.140 |
Why?
|
| Capacity Building | 1 | 2016 | 6 | 0.140 |
Why?
|
| Performance-Enhancing Substances | 1 | 2016 | 4 | 0.130 |
Why?
|
| Restraint, Physical | 1 | 2016 | 12 | 0.130 |
Why?
|
| Posture | 1 | 2016 | 39 | 0.130 |
Why?
|
| Caffeine | 1 | 2016 | 38 | 0.130 |
Why?
|
| Regression Analysis | 4 | 2011 | 209 | 0.130 |
Why?
|
| Acid Phosphatase | 1 | 2015 | 6 | 0.130 |
Why?
|
| Tartrate-Resistant Acid Phosphatase | 1 | 2015 | 7 | 0.120 |
Why?
|
| Clothing | 1 | 2015 | 4 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 65 | 0.120 |
Why?
|
| Isoenzymes | 1 | 2015 | 86 | 0.120 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2014 | 11 | 0.120 |
Why?
|
| Volition | 1 | 2014 | 5 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 1924 | 0.120 |
Why?
|
| Manometry | 2 | 2012 | 38 | 0.120 |
Why?
|
| Carotid Arteries | 1 | 2014 | 52 | 0.110 |
Why?
|
| Femoral Artery | 1 | 2014 | 58 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2012 | 857 | 0.110 |
Why?
|
| Foot | 2 | 2008 | 21 | 0.110 |
Why?
|
| Creatine Kinase | 1 | 2013 | 13 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 15 | 0.110 |
Why?
|
| Mississippi | 1 | 2013 | 5 | 0.110 |
Why?
|
| Supine Position | 1 | 2013 | 4 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 34 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 400 | 0.110 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2010 | 42 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2013 | 116 | 0.110 |
Why?
|
| Venous Pressure | 1 | 2012 | 2 | 0.100 |
Why?
|
| Ideal Body Weight | 1 | 2012 | 2 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 144 | 0.100 |
Why?
|
| Acute Disease | 1 | 2012 | 156 | 0.100 |
Why?
|
| Plethysmography | 1 | 2012 | 27 | 0.100 |
Why?
|
| Extracellular Fluid | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2012 | 2 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2012 | 50 | 0.100 |
Why?
|
| Macula Lutea | 1 | 2011 | 5 | 0.100 |
Why?
|
| Japan | 4 | 2012 | 22 | 0.100 |
Why?
|
| Retinal Neurons | 1 | 2011 | 13 | 0.100 |
Why?
|
| Cardiac Output | 1 | 2011 | 36 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2011 | 53 | 0.100 |
Why?
|
| Military Personnel | 1 | 2012 | 45 | 0.100 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 15 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 140 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2009 | 2261 | 0.090 |
Why?
|
| Aorta | 1 | 2012 | 123 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2011 | 25 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2011 | 18 | 0.090 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 346 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2011 | 31 | 0.090 |
Why?
|
| Leptin | 1 | 2011 | 66 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 290 | 0.090 |
Why?
|
| Mountaineering | 1 | 2010 | 6 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2011 | 111 | 0.090 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 31 | 0.090 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2010 | 9 | 0.090 |
Why?
|
| Vasodilation | 1 | 2011 | 114 | 0.090 |
Why?
|
| Whey Proteins | 1 | 2010 | 11 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2010 | 18 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2010 | 100 | 0.090 |
Why?
|
| Contraindications | 1 | 2009 | 13 | 0.090 |
Why?
|
| Estrogens | 1 | 2010 | 56 | 0.090 |
Why?
|
| Body Height | 1 | 2009 | 58 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 102 | 0.080 |
Why?
|
| Amputees | 1 | 2008 | 7 | 0.080 |
Why?
|
| Neoplasms | 1 | 2017 | 748 | 0.080 |
Why?
|
| Anatomy, Cross-Sectional | 2 | 2011 | 7 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 1998 | 44 | 0.070 |
Why?
|
| Wrestling | 2 | 1998 | 7 | 0.070 |
Why?
|
| Knee Joint | 1 | 2007 | 40 | 0.070 |
Why?
|
| Rest | 2 | 2020 | 93 | 0.070 |
Why?
|
| Life Style | 2 | 2012 | 83 | 0.070 |
Why?
|
| United States | 3 | 2012 | 2030 | 0.070 |
Why?
|
| Sports | 1 | 2006 | 23 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2007 | 87 | 0.070 |
Why?
|
| Animals | 3 | 2012 | 9932 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2011 | 801 | 0.070 |
Why?
|
| Pliability | 1 | 2005 | 6 | 0.060 |
Why?
|
| Electric Impedance | 1 | 2005 | 30 | 0.060 |
Why?
|
| Isotonic Contraction | 1 | 2005 | 6 | 0.060 |
Why?
|
| Reaction Time | 2 | 2019 | 93 | 0.060 |
Why?
|
| Kidney | 1 | 2006 | 275 | 0.060 |
Why?
|
| Sports Medicine | 1 | 2004 | 12 | 0.060 |
Why?
|
| Body Size | 1 | 2004 | 30 | 0.060 |
Why?
|
| Gymnastics | 1 | 2004 | 4 | 0.060 |
Why?
|
| Menstruation | 1 | 2004 | 9 | 0.060 |
Why?
|
| Liver | 1 | 2006 | 415 | 0.060 |
Why?
|
| Hyperalgesia | 1 | 2022 | 16 | 0.050 |
Why?
|
| Ice | 1 | 2022 | 9 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 84 | 0.050 |
Why?
|
| Hormones | 1 | 2022 | 41 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2022 | 15 | 0.050 |
Why?
|
| Body Water | 1 | 2001 | 19 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2001 | 27 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 115 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2000 | 509 | 0.050 |
Why?
|
| Ergometry | 2 | 1997 | 7 | 0.050 |
Why?
|
| Algorithms | 2 | 2012 | 419 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 80 | 0.040 |
Why?
|
| Physical Stimulation | 2 | 2012 | 70 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 2020 | 14 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 46 | 0.040 |
Why?
|
| Child | 3 | 2011 | 2141 | 0.040 |
Why?
|
| Diet | 2 | 1998 | 223 | 0.040 |
Why?
|
| Picolinic Acids | 1 | 1998 | 2 | 0.040 |
Why?
|
| Prevalence | 2 | 2012 | 472 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2018 | 11 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 81 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 165 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2000 | 116 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 92 | 0.040 |
Why?
|
| Densitometry | 1 | 1998 | 9 | 0.040 |
Why?
|
| Capillaries | 1 | 1998 | 32 | 0.040 |
Why?
|
| Back | 1 | 1997 | 1 | 0.040 |
Why?
|
| Hip | 1 | 1997 | 12 | 0.040 |
Why?
|
| Thorax | 1 | 1997 | 28 | 0.040 |
Why?
|
| Schools | 1 | 2018 | 69 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 1997 | 2 | 0.040 |
Why?
|
| Esterases | 1 | 1997 | 16 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 160 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 60 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 108 | 0.030 |
Why?
|
| Cancer Survivors | 1 | 2017 | 37 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 461 | 0.030 |
Why?
|
| Thumb | 1 | 1996 | 9 | 0.030 |
Why?
|
| Fingers | 1 | 1996 | 16 | 0.030 |
Why?
|
| Skin Temperature | 1 | 2015 | 5 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 628 | 0.030 |
Why?
|
| Forecasting | 1 | 1995 | 71 | 0.030 |
Why?
|
| Body Temperature | 1 | 2015 | 30 | 0.030 |
Why?
|
| Water | 1 | 2015 | 131 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 17 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2015 | 84 | 0.030 |
Why?
|
| Rats | 1 | 1997 | 1539 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 1392 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 59 | 0.030 |
Why?
|
| Brazil | 1 | 2012 | 21 | 0.030 |
Why?
|
| Germany | 1 | 2012 | 24 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 16 | 0.020 |
Why?
|
| Ethynodiol Diacetate | 1 | 2011 | 3 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 5 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 110 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 89 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 446 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 241 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 118 | 0.020 |
Why?
|
| Health Behavior | 1 | 2011 | 153 | 0.020 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2009 | 3 | 0.020 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2009 | 19 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 385 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 759 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 1087 | 0.020 |
Why?
|
| Menstruation Disturbances | 1 | 2004 | 3 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2003 | 15 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 23 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 70 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 77 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 75 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 54 | 0.010 |
Why?
|
| Mathematics | 1 | 2002 | 42 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 261 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 546 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2000 | 9 | 0.010 |
Why?
|
| Calcium, Dietary | 1 | 2000 | 11 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 586 | 0.010 |
Why?
|
| Placebos | 1 | 1998 | 45 | 0.010 |
Why?
|
| Anaerobic Threshold | 1 | 1998 | 19 | 0.010 |
Why?
|
| Acceleration | 1 | 1997 | 16 | 0.010 |
Why?
|
| Insulin | 1 | 1998 | 310 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 72 | 0.010 |
Why?
|
| African Americans | 1 | 1997 | 350 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1990 | 391 | 0.000 |
Why?
|